NYSE · Basic Materials · Specialty Chemicals · USA
Ashland Inc is a mid cap company (market value between $2 billion and $10 billion) in the Specialty Chemicals industry.
Ashland Inc produces additives and specialty ingredients for coatings, construction, pharmaceuticals and food markets. The company operates four segments: Life Sciences supplies pharmaceutical and nutrition solutions; Personal Care provides cosmetic and household ingredients; Specialty Additives delivers rheology modifiers for industrial applications; and Intermediates manufactures chemical intermediates and process solvents. Operations span the Americas, Europe and Asia Pacific.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Ashland Inc stock.
Overvalued: intrinsic value $15.36 per share, market price $71.19, margin of safety -363.4% (as of 2026-10-19).
Its through-the-cycle earnings (2.7% median margin), capitalised at 7.7% with no growth, values the shares at $15.36; the price of $71.19 is 363% above that value.
Leak Score: 38/100 on 11 of 12 signals (On Watch).
17 more funds hold it; the full list is part of the paid plan.
All 62 Specialty Chemicals stocks
34 more in this industry show a wider margin of safety.
ASH is overvalued (as of the 2026-10-19 close). Its through-the-cycle earnings (2.7% median margin), capitalised at 7.7% with no growth, values the shares at $15.36; the price of $71.19 is 363% above that value.
$15.36 per share (as of the 2026-10-19 close), against a market price of $71.19. That is a margin of safety of -363.4%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
38 out of 100, which we rate "On Watch", on 11 of 12 value investing signals.